Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bierman

Showing results (231-240 of 253) with videos related to

Pageof 26
Sort By:
British Journal of Haematology|October 24, 2006
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) projectCharles L Bennett, Andrew M Evens, Leslie A Andritsos, et al.
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.
Leukemia & Lymphoma|April 2, 2015
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcomeGabriel C Caponetti, Bhavana J Dave, Anamarija M Perry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryH M Lazarus, P A Rowlings, M J Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2009
Antiemesis. Clinical Practice Guidelines in OncologyDavid S Ettinger, Debra K Armstrong, Sally Barbour, et al.
British Journal of Haematology|February 11, 2014
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximabAnamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2012
AntiemesisDavid S Ettinger, Debra K Armstrong, Sally Barbour, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 2, 2006
Hodgkin disease/lymphoma. Clinical practice guidelines in oncologyRichard T Hoppe, Ranjana Hira Advani, Philip J Bierman, et al.
Transplantation|September 23, 2003
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantationSteven Z Pavletic, R Gregory Bociek, James M Foran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trialJ M Vose, A N Pandite, R A Beveridge, et al.
Pageof 26

Showing results (231-240 of 253) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|October 24, 2006
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) projectCharles L Bennett, Andrew M Evens, Leslie A Andritsos, et al.
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.
Leukemia & Lymphoma|April 2, 2015
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcomeGabriel C Caponetti, Bhavana J Dave, Anamarija M Perry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryH M Lazarus, P A Rowlings, M J Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2009
Antiemesis. Clinical Practice Guidelines in OncologyDavid S Ettinger, Debra K Armstrong, Sally Barbour, et al.
British Journal of Haematology|February 11, 2014
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximabAnamarija M Perry, Yuridia Alvarado-Bernal, Javier A Laurini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2012
AntiemesisDavid S Ettinger, Debra K Armstrong, Sally Barbour, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 2, 2006
Hodgkin disease/lymphoma. Clinical practice guidelines in oncologyRichard T Hoppe, Ranjana Hira Advani, Philip J Bierman, et al.
Transplantation|September 23, 2003
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantationSteven Z Pavletic, R Gregory Bociek, James M Foran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trialJ M Vose, A N Pandite, R A Beveridge, et al.
Pageof 26